Hemostatic biomarkers levels for the identification of cancer patients at higher VTE risk enrolled in the HYPERCAN study. Issue 164 (April 2018) - Verzeroli, C.; Marchetti, M.; Giaccherini, C.; Masci, G.; Celio, L.; Merelli, B.; Sarmiento, R.; Ghilardi, M.; Brevi, S.; Gamba, S.; Milesi, V.; Raffaeli, D.; et al.